<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="One type pertains to the M2 ion channel inhibitors, including" exact="amantadine" post="and rimantadine, which block the release of viral RNA"/>
 <result pre="described previously [27]. Briefly, the known saponin 3-(β- d-glucopyranosyl)-oleanolic acid" exact="benzyl ester" post="or 3-(α- d-mannopyranosyl)-oleanolic acid benzyl ester was subjected to"/>
 <result pre="saponin 3-(β- d-glucopyranosyl)-oleanolic acid benzyl ester or 3-(α- d-mannopyranosyl)-oleanolic acid" exact="benzyl ester" post="was subjected to PivCl in the presence of pyridine"/>
 <result pre="acyl groups with NaOH to produce two tridesmosidic oleanolic acid" exact="benzyl ester" post="saponins, respectively. Hydrogenolysis of the above oleanolic acid benzyl"/>
 <result pre="benzyl ester saponins, respectively. Hydrogenolysis of the above oleanolic acid" exact="benzyl ester" post="saponins over palladium/carbon in THF-MeOH led to OA-9 and"/>
 <result pre="purities of all oleanane-type triterpenoids were ≥98% by HPLC analysis." exact="Ribavirin" post="hydrochloride was purchased from Guangdong Starlake Bioscience Co. Ltd."/>
 <result pre="Starlake Bioscience Co. Ltd. (Zhaoqing, China) with purities ≥ 99%." exact="Peramivir" post="in sterile 0.9% NaCl solution (0.3 g/100 mL) was"/>
 <result pre="(Dalian, China) with purities ≥98%. Oleanane-type triterpenoids were dissolved in" exact="dimethyl sulfoxide" post="(DMSO) and diluted with PBS to &amp;lt;0.4% DMSO for"/>
 <result pre="diluted with PBS to &amp;lt;0.4% DMSO for in vitro experiments." exact="Ribavirin" post="hydrochloride was dissolved in PBS for in vitro experiments."/>
 <result pre="Beit Haemek, Israel), 100 U/mL of penicillin and 100 µg/mL" exact="streptomycin" post="in a humidified atmosphere with 5% CO2. All cells"/>
 <result pre="(0.1 MOI) for 1 h at 37 °C. OA-10 or" exact="ribavirin" post="or peramivir was added before, during or after IAV"/>
 <result pre="for 1 h at 37 °C. OA-10 or ribavirin or" exact="peramivir" post="was added before, during or after IAV infection. For"/>
 <result pre="in fresh medium. In total, 80 µM of OA-10 or" exact="ribavirin" post="or peramivir was then added for 0 to 2,"/>
 <result pre="medium. In total, 80 µM of OA-10 or ribavirin or" exact="peramivir" post="was then added for 0 to 2, 2 to"/>
 <result pre="in this study. Our results showed that 15 μM of" exact="peramivir" post="exhibited a significant inhibition on IAV infections in the"/>
 <result pre="antiviral effects during virus entry. In these assays, 15 μM" exact="peramivir" post="exhibited more significant inhibition on H5N1 IAV’s replication in"/>
 <result pre="replication in both co-treatment and post-treatment modes, while 30 μM" exact="ribavirin" post="exhibited inhibition only in the post-treatment mode, and its"/>
 <result pre="addition, the combination of 40 μM OA-10 and 15 μM" exact="ribavirin" post="treatment showed a synergistic effect on reducing progeny virus"/>
 <result pre="infection; i.e., virus internalization, endosome fusion, RNA release and replication." exact="Ribavirin" post="inhibits viral RNA synthesis. As expected, it exerted better"/>
 <result pre="inhibition when added after 4 hpi. On the other hand," exact="peramivir" post="blocks progeny virus release from infected cells, and did"/>
 <result pre="entry by OA-10 (earlier step) and polymerase-mediated RNA replication by" exact="ribavirin" post="(later step). It is expected that using an inhibitor"/>
 <result pre="is expected that using an inhibitor like OA-10 together with" exact="ribavirin" post="or NA inhibitors would not only enhance antiviral effects"/>
 <result pre="fresh medium containing various concentrations of OA-10 or 15 µM" exact="peramivir" post="(Per). At 24 hpi, the cells were fixed with"/>
 <result pre="was used to digitize image OD. Results from OA-10 or" exact="peramivir" post="or ribavirin treated samples were compared to those from"/>
 <result pre="to digitize image OD. Results from OA-10 or peramivir or" exact="ribavirin" post="treated samples were compared to those from corresponding DMSO-treated"/>
 <result pre="for 1 h. After two washes with PBS, OA-10 or" exact="ribavirin" post="or peramivir was added at the indicated time points"/>
 <result pre="h. After two washes with PBS, OA-10 or ribavirin or" exact="peramivir" post="was added at the indicated time points and removed"/>
</results>
